Simvastatine [French] en es it fr

Simvastatine [French] Brand names, Simvastatine [French] Analogs

Simvastatine [French] Brand Names Mixture

  • No information avaliable

Simvastatine [French] Chemical_Formula


Simvastatine [French] RX_link

Simvastatine [French] fda sheet

Simvastatine_[French] FDA

Simvastatine [French] msds (material safety sheet)

Simvastatine [French] Synthesis Reference

W. F. Hoffman et al., U.S. Pat. 4,444,784 (1984)

Simvastatine [French] Molecular Weight

418.566 g/mol

Simvastatine [French] Melting Point


Simvastatine [French] H2O Solubility

0.76 mg/L

Simvastatine [French] State


Simvastatine [French] LogP


Simvastatine [French] Dosage Forms

Tablet (oral)

Simvastatine [French] Indication

For the treatment of hypercholesterolemia.

Simvastatine [French] Pharmacology

Simvastatin, the methylated form of lovastatin, is an oral antilipemic agent which inhibits HMG-CoA reductase. simvastatin is used in the treatment of primary hypercholesterolemia and is effective in reducing total and LDL-cholesterol as well as plasma triglycerides and apolipoprotein B.

Simvastatine [French] Absorption

Absorption of simvastatin, estimated relative to an intravenous reference dose, in each of two animal species tested, averaged about 85% of an oral dose. In animal studies, after oral dosing, simvastatin achieved substantially higher concentrations in the liver than in non-target tissues.

Simvastatine [French] side effects and Toxicity

No information avaliable

Simvastatine [French] Patient Information

Patients should be advised about substances they should not take concomitantly with simvastatin and be advised to report promptly unexplained muscle pain, tenderness, or weakness. Patients should also be advised to inform other physicians prescribing a new medication that they are taking ZOCOR.

Simvastatine [French] Organisms Affected

Humans and other mammals